§ 287.
(a)
Purpose
The purpose of the National Center for Advancing Translational Sciences (in this subpart referred to as the “Center”) is to advance translational sciences, including by—
(1)
coordinating and developing resources that leverage basic research in support of translational science; and
(2)
developing partnerships and working cooperatively to foster synergy in ways that do not create duplication, redundancy, and competition with industry activities.
(c)
Biennial report
The Center shall publish a report on a biennial basis that, with respect to all research supported by the Center, includes a complete list of—
(1)
the molecules being studied;
(2)
clinical trial activities being conducted;
(3)
the methods and tools in development;
(4)
ongoing partnerships, including—
(A)
the rationale for each partnership;
(B)
the status of each partnership;
(C)
the funding provided by the Center to other entities pursuant to each partnership, and
(D)
the activities which have been transferred to industry pursuant to each partnership;
(5)
known research activity of other entities that is or will expand upon research activity of the Center;
(6)
the methods and tools, if any, that have been developed since the last biennial report was prepared; and
(7)
the methods and tools, if any, that have been developed and are being utilized by the Food and Drug Administration to support medical product reviews.
([July 1, 1944, ch. 373], title IV, § 479, as added [Pub. L. 99–158, § 2], Nov. 20, 1985, [99 Stat. 864]; amended [Pub. L. 103–43, title XV, § 1501(2)(B)], June 10, 1993, [107 Stat. 172]; [Pub. L. 112–74, div. F, title II, § 221(a)(1)(C)], Dec. 23, 2011, [125 Stat. 1086]; [Pub. L. 114–255, div. A, title II], §§ 2037, 2042(e), Dec. 13, 2016, [130 Stat. 1063], 1073.)